The Role of Bispecific Antibodies in Relapsed Refractory Multiple Myeloma: A Systematic Review

Multiple myeloma is a heterogeneous clonal malignant plasma cell disorder, which remains incurable despite the therapeutic armamentarium’s evolution. Bispecific antibodies (BsAbs) can bind simultaneously to the CD3 T-cell receptor and tumor antigen of myeloma cells, causing cell lysis. This systemat...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Razwana Khanam, Omer S. Ashruf, Syed Hamza Bin Waqar, Zunairah Shah, Saba Batool, Rameesha Mehreen, Pranali Pachika, Zinath Roksana, Mohammad Ebad Ur Rehman, Faiz Anwer
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2023-05-01
Edice:	Antibodies
Témata:	bispecific antibodies relapsed refractory multiple myeloma teclistamab elranatamb talquetamab
On-line přístup:	https://www.mdpi.com/2073-4468/12/2/38
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!